Le Lézard
Classified in: Health
Subject: SVY

$1.70 Bn Clinical Trial Management System Market - Global Forecasts to 2024


DUBLIN, March 20, 2019 /PRNewswire/ -- The "Clinical Trial Management System Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global clinical trial management system (CTMS) market is expected to reach US$1,704.371 million by 2024 from US$948.962 million in 2018 growing at a CAGR of 10.25%.

Clinical trial management system (CTMS) is a web based technology solution that centralizes the management aspect of clinical trials resulting in streamline business processes, enhanced efficiency, reduced administrative work and reduced time and cost of clinical trials. Key application area for CTMS include protocol development, data analysis and reporting, collection, monitoring and processing of data, site selection and trial preparation etc.

The Clinical Trial Management System (CTMS) market is anticipated to show significant growth during the forecast period rising number of drug development and clinical research activities. Growing trend towards integrating Hospital Information System (HIS) with CTMS will also augment the growth of the market.

Rising demand of the CTMS to reduce the cost and administrative burden of the clinical will also boost the adoption of CTMS, thus, having a positive impact on the market. However, issues related to the data security coupled with the high cost of CTMS might hinder the growth of the market during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region.

Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Key Topics Covered:

1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base and Forecast Years Timeline

2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. Key Findings of the Study

4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter's Five Forces Analysis
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. Global Clinical Trial Management System (CTMS) Market Forecast by Type
5.1. Enterprise CTMS
5.2. Site CTMS

6. Global Clinical Trial Management System (CTMS) Market Forecast by Deployment Model
6.1. Cloud Based CTMS
6.2. On Premise CTMS

7. Global Clinical Trial Management System (CTMS) Market Forecast by Component
7.1. Services
7.2. Software

8. Global Clinical Trial Management System (CTMS) Market Forecast by End User
8.1. Pharmaceutical and Biopharmaceutical Companies
8.2. Other Healthcare Providers
8.3. Cros

9. Global Clinical Trial Management System (CTMS) Market Forecast by Geography
9.1. North America
9.1.1. The U.S
9.1.2. Canada
9.1.3. Mexico
9.1.4. Others
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. U.K.
9.3.2. France
9.3.3. Germany
9.3.4. Italy
9.3.5. Others
9.4. Middle East and Africa
9.4.1. Saudi Arabia
9.4.2. Uae
9.4.3. Israel
9.4.4. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. India
9.5.3. Australia
9.5.4. South Korea
9.5.5. Others

10. Competitive Intelligence
10.1. Competition and Offerings Analysis of Key Vendors
10.2. Strategies of Key Players
10.3. Recent Investments and Deals

11. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/hdv3j9/1_70_bn_clinical?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 06:50
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...



News published on and distributed by: